152 related articles for article (PubMed ID: 19003369)
1. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.
Merten OW; Kallel H; Manuguerra JC; Tardy-Panit M; Crainic R; Delpeyroux F; Van der Werf S; Perrin P
Cytotechnology; 1999 Jul; 30(1-3):191-201. PubMed ID: 19003369
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
Merten OW; Kierulff JV; Castignolles N; Perrin P
Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112
[TBL] [Abstract][Full Text] [Related]
3. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.
Merten OW; Wu R; Couvé E; Crainic R
Cytotechnology; 1997 Nov; 25(1-3):35-44. PubMed ID: 22358877
[TBL] [Abstract][Full Text] [Related]
5. A simple serum-free freezing medium for serum-free cultured cells.
Merten OW; Petres S; Couvé E
Biologicals; 1995 Jun; 23(2):185-9. PubMed ID: 7546662
[TBL] [Abstract][Full Text] [Related]
6. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
7. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
8. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
[TBL] [Abstract][Full Text] [Related]
9. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
10. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
11. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
12. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
Merten OW
Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
[TBL] [Abstract][Full Text] [Related]
13. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
Rourou S; Ben Zakkour M; Kallel H
Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
[TBL] [Abstract][Full Text] [Related]
16. Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.
Hu AY; Tseng YF; Weng TC; Liao CC; Wu J; Chou AH; Chao HJ; Gu A; Chen J; Lin SC; Hsiao CH; Wu SC; Chong P
PLoS One; 2011 Jan; 6(1):e14578. PubMed ID: 21283675
[TBL] [Abstract][Full Text] [Related]
17. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.
Mattos DA; Silva MV; Gaspar LP; Castilho LR
Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117
[TBL] [Abstract][Full Text] [Related]
18. Higher production of rabies virus in serum-free medium cell cultures on microcarriers.
Frazzati-Gallina NM; Paoli RL; Mourão-Fuches RM; Jorge SA; Pereira CA
J Biotechnol; 2001 Dec; 92(1):67-72. PubMed ID: 11604174
[TBL] [Abstract][Full Text] [Related]
19. Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.
Castro R; Fernandes P; Laske T; Sousa MF; Genzel Y; Scharfenberg K; Alves PM; Coroadinha AS
Appl Microbiol Biotechnol; 2015 Sep; 99(17):7059-68. PubMed ID: 25994255
[TBL] [Abstract][Full Text] [Related]
20. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
